Type
. Interleukin-17F single-nucleotide polymorphism (7488T>C) and its association with susceptibility to leprosy. International journal of immunogenetics. 2014;41(2):131-7.
Type
. Immunocytochemical detection of mycobacterial antigen in extrapulmonary tuberculosis. Diagnostic cytopathology. 2014;42(5):391-5.
Type
. Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. International journal of dermatology. 2014;53(1):109-13.
Type
. FoxP3 provides competitive fitness to CD4⁺CD25⁺ T cells in leprosy patients via transcriptional regulation. European journal of immunology. 2014;44(2):431-9.
Type
. Communities of the afflicted: constituting leprosy through place in South India. Medical anthropology. 2014;33(1):6-20.
Type
. Gender-based attitudes, HIV misconceptions and feelings towards marginalized groups are associated with stigmatization in Mumbai, India. Journal of biosocial science. 2014;:1-16.
Type
. First report of canine leprosy in Europe: molecular and clinical traits. The Veterinary record. 2014;174(5):120.
Type
. A strategy to halt leprosy transmission. The Lancet. Infectious diseases [Internet]. 2014;14(2):96-8. Available from: http://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(13)70365-7.pdf
Type
. Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day. Anais brasileiros de dermatologia [Internet]. 2014;89(2):266-72. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008057/pdf/abd-89-02-0266.pdf
Type
. Rabies, tetanus, leprosy, and malaria. Handbook of clinical neurology. 2014;121:1501-20.